Corbus Pharmaceuticals Holdings (CRBP) Other Gross PP&E Adjustments (2014 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Other Gross PP&E Adjustments of $3.4 million in Q4 2025, up 9.09% quarter-over-quarter from $3.1 million in Q3 2025, and up 45.51% on a YoY basis from $2.3 million in Q4 2024.
Corbus Pharmaceuticals Holdings (CRBP) Other Gross PP&E Adjustments (2014 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings' Other Gross PP&E Adjustments history runs 12 years deep, the most recent figure standing at $3.4 million for Q4 2025.
- In Q4 2025, Other Gross PP&E Adjustments rose 45.51% year-over-year to $3.4 million; the TTM figure through Dec 2025 stood at $3.4 million (up 45.51% YoY), while the FY2025 annual figure was $3.4 million, up 45.51% from the prior year.
- Other Gross PP&E Adjustments was $3.4 million for Q4 2025 at Corbus Pharmaceuticals Holdings, up from $3.1 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $3.4 million in Q4 2025 to a low of $155828.0 in Q4 2021.
- Historically, Other Gross PP&E Adjustments has averaged $1.5 million across 5 years, with a median of $1.4 million in 2021.
- The sharpest annual moves came in 2021 and 2022: Other Gross PP&E Adjustments tumbled 86.66% in 2021, then jumped 428.01% in 2022.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at $155828.0 in 2021, then surged by 428.01% to $822786.0 in 2022, then jumped by 78.18% to $1.5 million in 2023, then surged by 58.59% to $2.3 million in 2024, then soared by 45.51% to $3.4 million in 2025.
- The last three Other Gross PP&E Adjustments figures came in at $3.4 million (Q4 2025), $3.1 million (Q3 2025), and $2.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | -60,691.22 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -83,048.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -285.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -892,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -1.69 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 133.67 Mn | 105.86 Mn | - | 3.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.38 Mn |
| Dec 31, 2025 | 3.38 Mn |
| Sep 30, 2025 | 3.10 Mn |
| Sep 30, 2025 | 3.10 Mn |
| Jun 30, 2025 | 2.83 Mn |
| Jun 30, 2025 | 2.83 Mn |
| Mar 31, 2025 | 2.58 Mn |
| Mar 31, 2025 | 2.58 Mn |
| Dec 31, 2024 | 2.33 Mn |
| Dec 31, 2024 | 2.33 Mn |
| Sep 30, 2024 | 2.15 Mn |
| Sep 30, 2024 | 2.15 Mn |
| Jun 30, 2024 | 1.92 Mn |
| Jun 30, 2024 | 1.92 Mn |
| Mar 31, 2024 | 1.69 Mn |
| Mar 31, 2024 | 1.69 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Sep 30, 2023 | 1.25 Mn |